Smith & Nephew PLC
SNN27.000USD
+0.480+1.81%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
11.79BMarktkapitalisierung
--KGV TTM
mehr Informationen über Smith & Nephew PLC Unternehmen
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Unternehmensinformationen
Unternehmens-codeSNN
Name des UnternehmensSmith & Nephew PLC
IPO-datumAug 13, 1951
Gegründet am1937
CEOMr. Deepak S. Nath
Anzahl der mitarbeiter17349
WertpapierartEquity Future
GeschäftsjahresendeAug 13
AddresseBuilding 5
StadtWATFORD
BörseJohannesburg Stock Exchange
LandUnited Kingdom
PostleitzahlWD18 8YE
Telefon4401923477100
Websitehttps://www.smith-nephew.com/
Unternehmens-codeSNN
IPO-datumAug 13, 1951
Gegründet am1937
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Mr. Bob White
Mr. Bob White
Non-Executive Independent Director
Non-Executive Independent Director
4.19K
+6.56%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
1.82K
+34.44%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
1.81K
+34.67%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.14K
+10.42%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.07K
+42.27%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
809.00
+47.90%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
490.00
+1.94K%
Mr. Jeremy Kim (Jez) Maiden
Mr. Jeremy Kim (Jez) Maiden
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Mr. Bob White
Mr. Bob White
Non-Executive Independent Director
Non-Executive Independent Director
4.19K
+6.56%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
1.82K
+34.44%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
1.81K
+34.67%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.14K
+10.42%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Fiduciary Management, Inc.
0.91%
Millennium Management LLC
0.78%
Barrow Hanley Global Investors
0.48%
Scharf Investments, LLC
0.47%
River Road Asset Management, LLC
0.46%
Other
96.89%
Aktionärsstatistik
Aktionäre
Anteil
Fiduciary Management, Inc.
0.91%
Millennium Management LLC
0.78%
Barrow Hanley Global Investors
0.48%
Scharf Investments, LLC
0.47%
River Road Asset Management, LLC
0.46%
Other
96.89%
Art
Aktionäre
Anteil
Investment Advisor
4.55%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
1.08%
Research Firm
0.37%
Family Office
0.22%
Family Office
0.17%
Family Office
0.17%
Private Equity
0.10%
Pension Fund
0.06%
Other
91.71%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
451
34.23M
7.82%
-10.03M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
2023Q1
461
43.45M
9.95%
-3.75M
2022Q4
459
43.39M
9.94%
-3.85M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fiduciary Management, Inc.
4.00M
0.91%
-233.06K
-5.51%
Dec 31, 2024
Millennium Management LLC
3.43M
0.78%
+3.43M
--
Dec 31, 2024
Barrow Hanley Global Investors
2.10M
0.48%
-1.84M
-46.70%
Dec 31, 2024
Scharf Investments, LLC
2.63M
0.6%
-268.93K
-9.27%
Dec 31, 2024
River Road Asset Management, LLC
2.03M
0.46%
+792.83K
+63.98%
Dec 31, 2024
J. Goldman & Co., L.P.
1.94M
0.44%
+1.94M
--
Dec 31, 2024
Brandes Investment Partners, L.P.
1.36M
0.31%
+138.99K
+11.36%
Dec 31, 2024
Parametric Portfolio Associates LLC
1.32M
0.3%
+197.28K
+17.57%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
894.41K
0.2%
-104.78K
-10.49%
Dec 31, 2024
The Clark Estates Inc.
800.00K
0.18%
+115.00K
+16.79%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Brandes International ETF
2.2%
ALPS Disruptive Technologies ETF
1.17%
ActivePassive International Equity ETF
0.13%
SPDR S&P Kensho New Economies Composite ETF
0.11%
SP Funds S&P World (ex-US) ETF
0.08%
Avantis Responsible International Equity ETF
0.07%
Avantis International Equity ETF
0.06%
DFA Dimensional International Core Equity 2 ETF
0.04%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
First Trust BuyWrite Income ETF
0%
Mehr Anzeigen
Brandes International ETF
Anteil2.2%
ALPS Disruptive Technologies ETF
Anteil1.17%
ActivePassive International Equity ETF
Anteil0.13%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.11%
SP Funds S&P World (ex-US) ETF
Anteil0.08%
Avantis Responsible International Equity ETF
Anteil0.07%
Avantis International Equity ETF
Anteil0.06%
DFA Dimensional International Core Equity 2 ETF
Anteil0.04%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
Anteil0%
First Trust BuyWrite Income ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.64B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Jul 29, 2020
SNN.NB Interim Cash Dividend of gross USD 0.288 paid on Oct 28, 2020 going ex on Oct 01, 2020
Oct 02, 2020
Oct 28, 2020
Oct 01, 2020
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten